“During Mental Health Awareness Month, we hear suicide prevention and mental health organizations promoting pharmaceutical products as treatments while staying silent about adverse drug effects that can harm our mental wellbeing,” said Wendy Dolin, MISSD founder.

See more at https://www.einpresswire.com/article/573938198/fda-black-box-label-warns-of-suicide-risks?r=pawvHNLdeLOjws8eSt